These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37128935)

  • 1. A pharmacological overview of aprepitant for the prevention of postoperative nausea and vomiting.
    Padilla A; Habib AS
    Expert Rev Clin Pharmacol; 2023; 16(6):491-505. PubMed ID: 37128935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
    Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
    Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprepitant: A New Modality for the Prevention of Postoperative Nausea and Vomiting: An Evidence-Based Review.
    Milnes V; Gonzalez A; Amos V
    J Perianesth Nurs; 2015 Oct; 30(5):406-17. PubMed ID: 26408515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis].
    Murakami C; Kakuta N; Satomi S; Nakamura R; Miyoshi H; Morio A; Saeki N; Kato T; Ohshita N; Tanaka K; Tsutsumi YM
    Braz J Anesthesiol; 2020; 70(5):508-519. PubMed ID: 32753114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting.
    Kranke P; Schuster F; Eberhart LH
    Expert Opin Pharmacother; 2007 Dec; 8(18):3217-35. PubMed ID: 18035965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting].
    Kienbaum P; Schaefer MS; Weibel S; Schlesinger T; Meybohm P; Eberhart LH; Kranke P
    Anaesthesist; 2022 Feb; 71(2):123-128. PubMed ID: 34596699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting?
    DiIorio TM; Sharkey PF; Hewitt AM; Parvizi J
    Clin Orthop Relat Res; 2010 Sep; 468(9):2405-9. PubMed ID: 20419358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprepitant for postoperative nausea and vomiting: a systematic review and meta-analysis.
    Singh PM; Borle A; Rewari V; Makkar JK; Trikha A; Sinha AC; Goudra B
    Postgrad Med J; 2016 Feb; 92(1084):87-98. PubMed ID: 26627976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: a systematic review and meta-analysis.
    Liu M; Zhang H; Du BX; Xu FY; Zou Z; Sui B; Shi XY
    Medicine (Baltimore); 2015 May; 94(19):e762. PubMed ID: 25984662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurokinin-1 receptor antagonism, aprepitant, effectively diminishes post-operative nausea and vomiting while increasing analgesic tolerance in laparoscopic gynecological procedures.
    Kakuta N; Tsutsumi YM; Horikawa YT; Kawano H; Kinoshita M; Tanaka K; Oshita S
    J Med Invest; 2011 Aug; 58(3-4):246-51. PubMed ID: 21921426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
    Therneau IW; Martin EE; Sprung J; Kellogg TA; Schroeder DR; Weingarten TN
    Obes Surg; 2018 Jan; 28(1):37-43. PubMed ID: 28674839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative nausea and vomiting in patients undergoing colorectal surgery within an institutional enhanced recovery after surgery protocol: comparison of two prophylactic antiemetic regimens.
    Holder-Murray J; Esper SA; Boisen ML; Gealey J; Meister K; Medich DS; Subramaniam K
    Korean J Anesthesiol; 2019 Aug; 72(4):344-350. PubMed ID: 31096730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial.
    Bergese S; Viloria A; Uribe A; Antor A; Fernandez S
    Trials; 2012 Aug; 13():130. PubMed ID: 22862827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The next generation of antiemetics for the management of postoperative nausea and vomiting.
    Tan HS; Dewinter G; Habib AS
    Best Pract Res Clin Anaesthesiol; 2020 Dec; 34(4):759-769. PubMed ID: 33288125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiemetic efficacy of combined aprepitant and dexamethasone in patients at high-risk of postoperative nausea and vomiting from epidural fentanyl analgesia.
    Kawano H; Matsumoto T; Hamaguchi E; Manabe S; Nakagawa M; Yamada A; Fujimoto M; Tada F
    Minerva Anestesiol; 2015 Apr; 81(4):362-8. PubMed ID: 25220550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprepitant vs. multimodal prophylaxis in the prevention of nausea and vomiting following extended-release epidural morphine.
    Hartrick CT; Tang YS; Hunstad D; Pappas J; Muir K; Pestano C; Silvasi D
    Pain Pract; 2010; 10(3):245-8. PubMed ID: 20230453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of aprepitant to prevent postoperative nausea in highly susceptible patients after gynecological laparoscopy.
    Jung WS; Kim YB; Park HY; Choi WJ; Yang HS
    J Anesth; 2013 Jun; 27(3):396-401. PubMed ID: 23224788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of aprepitant for the prevention of postoperative nausea and vomiting: A meta-analysis.
    Liu Y; Chen X; Wang X; Zhong H; He H; Liu Y; Liao Y; Pan Z; Hu W; Liu W; Zheng F
    Medicine (Baltimore); 2023 Jul; 102(29):e34385. PubMed ID: 37478247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin-1 receptor antagonists for the prevention of postoperative nausea and vomiting.
    Meyer TA; Habib AS; Wagner D; Gan TJ
    Pharmacotherapy; 2023 Sep; 43(9):922-934. PubMed ID: 37166582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting.
    Van Belle SJ; Cocquyt V
    Expert Opin Pharmacother; 2008 Dec; 9(18):3261-70. PubMed ID: 19040346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.